7
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Multi-Compartment 3D-Cultured Organ-on-a-Chip: Towards a Biomimetic Lymph Node for Drug Development

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The interaction of immune cells with drugs and/or with other cell types should be mechanistically investigated in order to reduce attrition of new drug development. However, they are currently only limited technologies that address this need. In our work, we developed initial but significant building blocks that enable such immune-drug studies. We developed a novel microfluidic platform replicating the Lymph Node (LN) microenvironment called LN-on-a-chip, starting from design all the way to microfabrication, characterization and validation in terms of architectural features, fluidics, cytocompatibility, and usability. To prove the biomimetics of this microenvironment, we inserted different immune cell types in a microfluidic device, which showed an in-vivo-like spatial distribution. We demonstrated that the developed LN-on-a-chip incorporates key features of the native human LN, namely, (i) similarity in extracellular matrix composition, morphology, porosity, stiffness, and permeability, (ii) compartmentalization of immune cells within distinct structural domains, (iii) replication of the lymphatic fluid flow pattern, (iv) viability of encapsulated cells in collagen over the typical timeframe of immunotoxicity experiments, and (v) interaction among different cell types across chamber boundaries. Further studies with this platform may assess the immune cell function as a step forward to disclose the effects of pharmaceutics to downstream immunology in more physiologically relevant microenvironments.

          Related collections

          Most cited references60

          • Record: found
          • Abstract: found
          • Article: not found

          Bio-inspired, bioengineered and biomimetic drug delivery carriers.

          Synthetic carriers such as polymer and lipid particles often struggle to meet clinical expectations. Natural particulates - that range from pathogens to mammalian cells - are therefore worth examining in more depth, as they are highly optimized for their specific functions in vivo and possess features that are often desired in drug delivery carriers. With a better understanding of these biological systems, in conjunction with the availability of advanced biotechnology tools that are useful for re-engineering the various natural systems, researchers have started to exploit natural particulates for multiple applications in the delivery of proteins, small interfering RNA and other therapeutic agents. Here, we review the natural drug delivery carriers that have provided the basis and inspiration for new drug delivery systems.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found

            Resolution of inflammation: a new therapeutic frontier.

            Dysregulated inflammation is a central pathological process in diverse disease states. Traditionally, therapeutic approaches have sought to modulate the pro- or anti-inflammatory limbs of inflammation, with mixed success. However, insight into the pathways by which inflammation is resolved has highlighted novel opportunities to pharmacologically manipulate these processes - a strategy that might represent a complementary (and perhaps even superior) therapeutic approach. This Review discusses the state of the art in the biology of resolution of inflammation, highlighting the opportunities and challenges for translational research in this field.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Stromal cell networks regulate lymphocyte entry, migration, and territoriality in lymph nodes.

              After entry into lymph nodes (LNs), B cells migrate to follicles, whereas T cells remain in the paracortex, with each lymphocyte type showing apparently random migration within these distinct areas. Other than chemokines, the factors contributing to this spatial segregation and to the observed patterns of lymphocyte movement are poorly characterized. By combining confocal, electron, and intravital microscopy, we showed that the fibroblastic reticular cell network regulated naive T cell access to the paracortex and also supported and defined the limits of T cell movement within this domain, whereas a distinct follicular dendritic cell network similarly served as the substratum for movement of follicular B cells. These results highlight the central role of stromal microanatomy in orchestrating cell migration within the LN.
                Bookmark

                Author and article information

                Journal
                Pharmaceutics
                Pharmaceutics
                pharmaceutics
                Pharmaceutics
                MDPI
                1999-4923
                19 May 2020
                May 2020
                : 12
                : 5
                : 464
                Affiliations
                [1 ]Healthcare Engineering Innovation Center, Biomedical Engineering Department, Khalifa University of Science and Technology, Abu Dhabi P.O. Box 127788, UAE; aya.shanti@ 123456ku.ac.ae (A.S.); bisansamara@ 123456gmail.com (B.S.); amal-shukri@ 123456hotmail.com (A.A.); nicholas.hallfors@ 123456ku.ac.ae (N.H.)
                [2 ]School of Mechanical & Aerospace Engineering, Nanyang Technological University, 50 Nanyang Avenue, Singapore 639798, Singapore; daccoto@ 123456ntu.edu.sg
                [3 ]Division of Engineering, New York University Abu Dhabi, Abu Dhabi P.O. Box 129188, UAE; jiranuwat.sapudom@ 123456nyu.edu (J.S.); aseel.alatoom@ 123456nyu.edu (A.A.); jeremy.teo@ 123456nyu.edu (J.T.)
                [4 ]Department of Biomedical and Mechanical Engineering, New York University, P.O. Box 903, New York, NY 10276-0903, USA
                [5 ]Department of Civil and Industrial Engineering, University of Pisa, 56122 Pisa, Italy; serena.danti@ 123456unipi.it
                Author notes
                [* ]Correspondence: cesare.stefanini@ 123456ku.ac.ae ; Tel.: +9712-501-8472
                [†]

                These authors contributed equally to this work.

                Author information
                https://orcid.org/0000-0001-6627-7713
                https://orcid.org/0000-0003-3169-5119
                https://orcid.org/0000-0001-6869-3833
                https://orcid.org/0000-0002-8155-8537
                Article
                pharmaceutics-12-00464
                10.3390/pharmaceutics12050464
                7284904
                32438634
                6ac3a430-f5d2-42d9-8e5f-cb10c70b85a5
                © 2020 by the authors.

                Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ( http://creativecommons.org/licenses/by/4.0/).

                History
                : 20 March 2020
                : 30 April 2020
                Categories
                Article

                biomimicry,drug development,lymph node,microfabrication,microfluidics,organ-on-a-chip

                Comments

                Comment on this article